lobbying_activities: 2112472
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2112472 | 97262875-0914-43b8-a421-34c7bdc7392b | Q1 | DAIICHI SANKYO, INC. | 316731 | DAIICHI SANKYO INC | 2018 | first_quarter | PHA | Discussions regarding opioid abuse Discussions regarding 340B drug discount program S.974,Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act of 2017) Discussions regarding PBM patient assistance limitations | 130000 | 0 | 0 | 2018-04-18T22:33:09.697000-04:00 |